These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
891 related articles for article (PubMed ID: 33834444)
1. Diagnostic and Therapeutic Nanomedicine. Joo J Adv Exp Med Biol; 2021; 1310():401-447. PubMed ID: 33834444 [TBL] [Abstract][Full Text] [Related]
2. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives. Ali ES; Sharker SM; Islam MT; Khan IN; Shaw S; Rahman MA; Uddin SJ; Shill MC; Rehman S; Das N; Ahmad S; Shilpi JA; Tripathi S; Mishra SK; Mubarak MS Semin Cancer Biol; 2021 Feb; 69():52-68. PubMed ID: 32014609 [TBL] [Abstract][Full Text] [Related]
3. Magnetic drug delivery and targeting: principles and applications. Babincova M; Babinec P Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec; 153(4):243-50. PubMed ID: 20208962 [TBL] [Abstract][Full Text] [Related]
4. Nanotechnologies for noninvasive measurement of drug release. Moore T; Chen H; Morrison R; Wang F; Anker JN; Alexis F Mol Pharm; 2014 Jan; 11(1):24-39. PubMed ID: 24215280 [TBL] [Abstract][Full Text] [Related]
5. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles]. Ozeki T; Tagami T Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498 [TBL] [Abstract][Full Text] [Related]
6. Application of nanotechnology in biomedicine. Navalakhe RM; Nandedkar TD Indian J Exp Biol; 2007 Feb; 45(2):160-5. PubMed ID: 17375555 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine. Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591 [TBL] [Abstract][Full Text] [Related]
8. Unique roles of nanotechnology in medicine and cancer. Alam F; Naim M; Aziz M; Yadav N Indian J Cancer; 2014; 51(4):506-10. PubMed ID: 26842179 [TBL] [Abstract][Full Text] [Related]
9. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics. Nguyen KT; Zhao Y Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438 [TBL] [Abstract][Full Text] [Related]
10. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882 [TBL] [Abstract][Full Text] [Related]
11. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients. Bhattacharjee S; Brayden DJ Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229 [TBL] [Abstract][Full Text] [Related]
12. Nanotechnology and nanomedicine: going small means aiming big. Teli MK; Mutalik S; Rajanikant GK Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866 [TBL] [Abstract][Full Text] [Related]
13. Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy. Chaturvedi VK; Singh A; Singh VK; Singh MP Curr Drug Metab; 2019; 20(6):416-429. PubMed ID: 30227814 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticles and cancer therapy: Perspectives for application of nanoparticles in the treatment of cancers. Aghebati-Maleki A; Dolati S; Ahmadi M; Baghbanzhadeh A; Asadi M; Fotouhi A; Yousefi M; Aghebati-Maleki L J Cell Physiol; 2020 Mar; 235(3):1962-1972. PubMed ID: 31441032 [TBL] [Abstract][Full Text] [Related]
15. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small. Tyagi P; Subramony JA J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619 [TBL] [Abstract][Full Text] [Related]
16. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine. Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081 [TBL] [Abstract][Full Text] [Related]
17. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832 [TBL] [Abstract][Full Text] [Related]
18. Surface-Engineered Cancer Nanomedicine: Rational Design and Recent Progress. Ahmad J; Ameeduzzafar ; Ahmad MZ; Akhter H Curr Pharm Des; 2020; 26(11):1181-1190. PubMed ID: 32056517 [TBL] [Abstract][Full Text] [Related]
19. Cancer nanomedicine: from drug delivery to imaging. Chow EK; Ho D Sci Transl Med; 2013 Dec; 5(216):216rv4. PubMed ID: 24353161 [TBL] [Abstract][Full Text] [Related]
20. Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy. Zhang Y; Li Z; Huang Y; Xu Y; Zou B Nanomedicine (Lond); 2023 Nov; 18(27):2081-2099. PubMed ID: 38078442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]